3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Surgical Wound Infection
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Fistula
1
Duodenal Neoplasms
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
7
Cisplatin
6
durvalumab
5
pembrolizumab
4
gemcitabine-oxaliplatin regimen
3
S 1 (combination)
3
Carboplatin
3
Trastuzumab
2
Paclitaxel
2
Capecitabine
2
tucatinib
1
tremelimumab
1
merestinib
1
irinotecan sucrosofate
1
envafolimab
1
Tegafur
1
Ramucirumab
1
Radiation
1
Psilocybin
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Leucovorin
1
Itraconazole
1
Immune Checkpoint Inhibitors
1
High-Throughput Nucleotide Sequencing
1
Fulvestrant
1
Fluorouracil
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Biliary Tract Neoplasms
×
Anti-Bacterial Agents
×
Clear all
NCT03631173
2026-04-28
MINIMUM
Oslo University Hospital
Phase NA
Active not recruiting
201 enrolled